SCHEMBL22454446

SCHEMBL22454446

CCC(OC)(c1cccc(OC)c1)[C@@H](C)CN(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.40
HTR2A P28223 3/20 0.40
KCNH2 Q12809 2/20 0.40
OPRM1 P35372 2/20 0.40
OPRD1 P41143 2/20 0.40
MRGPRX2 Q96LB1 1/20 0.40
CHRM3 P20309 1/20 0.40
HRH2 P25021 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRK1 P41145 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
AOC3 Q16853 3/20 0.38
CYP3A4 P08684 2/20 0.38
TAAR1 Q96RJ0 2/20 0.37
KIF11 P52732 1/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17750791 1.00 CYP2D6 (0.40) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL14987836 0.86 KCNH2 (0.41) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL14984858 0.85 KCNH2 (0.38) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL669655 0.85 KCNH2 (0.38) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL14516176 0.85 KCNH2 (0.46) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL755809 0.85 KCNH2 (0.46) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL14974361 0.85 KCNH2 (0.38) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL669373 0.85 KCNH2 (0.38) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL3160373 0.84 HTR2A (0.40) CYP2D6HTR2AKCNH2OPRM1OPRD1
SCHEMBL3166369 0.84 HTR2A (0.40) CYP2D6HTR2AKCNH2OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200299225-A1 PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL GRUNENTHAL GMBH (DE) 2020-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299225-A1 PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL COMT, CYP1A1, CYP2E1 CYP2D6 66/4885HTR2A 749/4885KCNH2 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.